
OLD Category: immuno-oncology
October 30, 2019 / Nature
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
October 25, 2019 / Mod Pathol.
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression
October 24, 2019 / J Immunother Cancer
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
October 23, 2019 / Mol Ther Oncolytics
Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1
October 23, 2019 / Sci Transl Med.
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade
October 21, 2019 / Clin Cancer Res
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
October 17, 2019 / Clin Cancer Res
CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy
October 1, 2019 / J Clin Invest
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
October 1, 2019 / Cancer Res